pith. sign in

USPTO: us-12648572 · published 2026-06-09 · patents · A01N 63/50· A01N 25/08· C12N 1/16· C12N 15/63· C12R 2001/87

Proteolytically stable U1-agatoxin-Ta1b variant polypeptides for pest control

Pith reviewed 2026-06-11 03:02 UTC · model grok-4.3

classification patents A01N 63/50A01N 25/08C12N 1/16C12N 15/63C12R 2001/87
keywords U1-agatoxin-Ta1bvariant polypeptidepesticidalproteolytic stabilitypest controlamino acid sequenceTVP
0
0 comments X

The pith

Specific U1-agatoxin-Ta1b variant polypeptides are claimed as proteolytically stable pesticides.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The patent establishes that certain engineered versions of the U1-agatoxin-Ta1b polypeptide function as pesticides while resisting breakdown by proteases. It identifies three particular amino acid sequences (SEQ ID NO: 2, 49, and 51) along with their salts as meeting these criteria. These variants are positioned as tools for pest control in agriculture. A sympathetic reader would focus on whether the sequences deliver both activity against pests and durability in field conditions.

Core claim

A pesticidal U1-agatoxin-Ta1b variant polypeptide (TVP) comprising the amino acid sequence set forth in any one of SEQ ID NO: 2, 49, or 51; or an agriculturally acceptable salt thereof.

What carries the argument

The TVP sequences (SEQ ID NO: 2, 49, or 51) that are asserted to combine pesticidal activity with proteolytic stability.

If this is right

  • The polypeptides can serve as active ingredients in pest control formulations.
  • Their stability supports longer-lasting effects in agricultural settings compared to less resistant proteins.
  • Agriculturally acceptable salts of the sequences expand options for formulation and delivery.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • If the sequences perform as claimed, they could be incorporated into crop protection products or expressed in transgenic plants.
  • The approach might extend to other toxin-based pesticides where proteolytic instability limits practical use.
  • Commercial development would require scaling production and confirming safety profiles beyond the sequences alone.

Load-bearing premise

The listed sequences actually deliver pesticidal effects and resistance to proteolytic degradation.

What would settle it

Laboratory or field tests demonstrating that polypeptides matching these sequences fail to control target pests or are rapidly degraded by proteases would disprove the claim.

read the original abstract

1 . A pesticidal U1-agatoxin-Ta1b variant polypeptide (TVP) comprising the amino acid sequence set forth in any one of SEQ ID NO: 2, 49, or 51; or an agriculturally acceptable salt thereof.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

1 major / 0 minor

Summary. The manuscript claims a pesticidal U1-agatoxin-Ta1b variant polypeptide (TVP) comprising the amino acid sequence set forth in any one of SEQ ID NO: 2, 49, or 51, or an agriculturally acceptable salt thereof, asserting these variants are proteolytically stable for pest control.

Significance. If the sequences were shown to confer the claimed pesticidal activity and proteolytic stability, the work could contribute to development of stable peptide-based biopesticides. However, the manuscript provides no supporting data, methods, or results, so no scientific significance can be assessed.

major comments (1)
  1. [Abstract/Claim 1] Abstract/Claim 1: The central assertion that the listed sequences are pesticidal and proteolytically stable is unsupported by any experimental evidence, bioassays, stability measurements, or methods. The document contains only the bare legal claim with no data linking the sequences to the asserted functions.

Simulated Author's Rebuttal

1 responses · 1 unresolved

We thank the referee for reviewing the document. We note that this is a patent claim (US-12648572) rather than a full scientific manuscript, which accounts for the format and content. We address the comment below.

read point-by-point responses
  1. Referee: [Abstract/Claim 1] Abstract/Claim 1: The central assertion that the listed sequences are pesticidal and proteolytically stable is unsupported by any experimental evidence, bioassays, stability measurements, or methods. The document contains only the bare legal claim with no data linking the sequences to the asserted functions.

    Authors: We agree that the provided text consists solely of the legal claim without any experimental data, methods, or results. This document is the claim language from a patent application; patent claims are concise legal assertions and do not embed supporting data. Any enabling disclosure or data would appear in the full patent specification, which is not reproduced here. The referee is correct that no evidence is present in this excerpt, so the claimed functions cannot be scientifically evaluated from the given text alone. revision: no

standing simulated objections not resolved
  • The document is a patent claim, not a scientific paper; therefore no experimental data or methods section exists to add or revise.

Circularity Check

0 steps flagged

No derivation chain or equations present; claim is a direct sequence listing

full rationale

The document consists solely of a patent claim listing specific amino acid sequences (SEQ ID NO: 2, 49, or 51) asserted to be pesticidal U1-agatoxin-Ta1b variants. There are no equations, derivations, fitted parameters, predictions, self-citations, or any mathematical steps that could reduce to inputs by construction. The reader's assessment of score 0.0 is confirmed: absence of any derivation chain means no circularity of the enumerated kinds can be identified. The claim's validity depends on external empirical evidence not provided here, but that is an evidentiary issue, not circularity.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

No scientific model, free parameters, axioms, or invented entities are present; the document is a sequence-based legal claim only.

pith-pipeline@v0.9.1-grok · 5630 in / 937 out tokens · 135917 ms · 2026-06-11T03:02:55.198827+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.